A: Telescopic view (4 nun, 0") of the right superior nasal cavity shows the puru lent discharge emanating fr om the area of the natural ostium ofthe sphenoid sinus between the superior turbinat e (ST) and the nasal septum (NS). B: Telescopic view (4 nun, 0') of the right transnasal sphenoidotomy ShOlI-S the enlarged natural ostium ofthe sphenoid sinus after the partial superior turbinectomy. Inset: CT demonstrat es the opacifica tion ofthe right sphenoid sill/IS and lateral extension. Co' Telescopic view (4 nun, 0; ofthe interior ofthe sphenoid sinus shows the fungus ball (arrow) and swollen mucosa. Do' The fungus ball (arrows) is seen with a closer view.
A 63-year-old man presented with a 6-month history of right-sided headache and pain behind the right eye. He had been treated with several antibiotics by his family physician prior to referral.
Clinical evaluation revealed some mucopuru lent discharge in the right superior nasal cavity and in the right nasopharyn x (figure,A) .Computedtomography (CT) ofthe sinuses revealed opacification of the right sphenoid sinus, but no evidence of bony erosion (figure, B). The patient elected to undergo right endoscopic sinus surgery for drainage purposes. Transnasal sphenoidotomy' was carried out with a microdebriderthrough the natural ostium of the right ). An insp issated fungus ball was found in the sphenoid sin us and removed (figure, C and D). The sphenoid sinus mucosa was not removed . Culture identified the fungus as a member ofthe Asp ergillus genus. Pos toperative ly, the patient was trea ted with nasa l sa line irrigations and antifunga l medications, and he recovered uneventfully. A follow -up endoscop ic exam inatio n I yea r later revealed a widely patent sphenoid sinus and no evidence of fungal involvement.
The role offunga l organisms in the pathophysio logy of chronic rhinosinusitis has gai ned increas ing attention in the rece nt literature. Reports ofa high incidence offunga l species in specimens obtained from pat ients wit h chronic rh inosinu sitis have prompted significant discuss ion.' Traditionally, descriptions ofthe clinica l presentations of funga l sinus disease have ranged from aggressive invasive funga l sinusitis in immu noco mpromised hosts to more indo lent forms in imm unocompetent patients. Invas ive funga l sin usitis is a dest ruct ive process that ca uses tissue necrosis and requires aggressive surg ical debridement as part of treatment. No ninvasive ' funga l sinus disease in immunocompetent pat ients is generally treated successfully with conservative surgical removal of the contents of the affected sinus.' Noninvasive forms includ e sinus mycetomas and allerg ic funga l sinusitis.
Major cr iteria for the presence of allergic funga l sinusitis include nasal po lyposis, evidence of IgE-mediated hypersensitivity, eosi nop hilic mucus, characteristic CT findings of unilatera l invo lveme nt and hyperdense areas in the affected sinus, and a positive funga l culture.' Current treatm ents generally involve surgica l removal of allerg ic mucus and drug therapy wit h a systemic cort icosteroid. Systemic antifunga ls have not prove n to be benefic ial, althoug h top ical ant ifungal sprays have been suggested as a possi ble adjunct to treatment.'
